1116
News

SCOR Global Life has made a strategic investment in BioSerenity, a French medical solutions company that aims to optimize the patient pathways in several chronic diseases through the design of connected devices, end-t

document
November 4, 2019 — 00:00

This publication presents some global information on kidney diseases, the definitions and basic notions, protective treatments, renal replacement therapies, disease progression information as well as proposed underwri

document
October 9, 2019 — 00:00

SOLEM supports our clients throughout the world to assess risks, including a dedicated Claims management section.

document
September 4, 2019 — 00:00

The growing use of economic-value-based metrics will greatly benefit longstanding reinsurers, writes Denis Kessler, Chairman and CEO of SCOR, for the CEO Forum